Can a shingles shot protect transplant patients? timing may be key.
NCT ID NCT05775718
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the shingles vaccine Shingrix works in people who have had a stem cell transplant. About 55 adults who received the vaccine at least a year after their transplant will have their immune responses measured. Researchers want to see if the timing of the vaccine after transplant affects protection and whether a third dose might help.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Hospital
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a peer coach help young people take control of their chronic illness?
- Can a website ease the emotional toll of stem cell transplants?
- New program helps caregivers of stem cell patients cope better
- Lifting weights to fight transplant After-Effects: a new hope for young survivors
- Should cancer patients get antibiotics for a dubious c. diff test? small trial seeks answers
- New study aims to ease the burden of stem cell recovery for patients and families